FAM
ALXN
Flaharty Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-3,051
| Closed | -$560K | – | 141 |
|
|
2021
Q2 | $560K | Sell |
3,051
-67
| -2% | -$12.3K | 0.12% | 67 |
|
|
2021
Q1 | $477K | Sell |
3,118
-21,401
| -87% | -$3.27M | 0.11% | 71 |
|
|
2020
Q4 | $3.83M | Sell |
24,519
-2,788
| -10% | -$436K | 0.96% | 23 |
|
|
2020
Q3 | $3.13M | Hold |
27,307
| – | – | 0.98% | 21 |
|
|
2020
Q2 | $3.07M | Hold |
27,307
| – | – | 1.08% | 21 |
|
|
2020
Q1 | $2.45M | Buy |
27,307
+2,194
| +9% | +$197K | 1.13% | 18 |
|
|
2019
Q4 | $2.72M | Sell |
25,113
-2,000
| -7% | -$216K | 0.96% | 18 |
|
|
2019
Q3 | $2.66M | Hold |
27,113
| – | – | 1.01% | 18 |
|
|
2019
Q2 | $3.55M | Sell |
27,113
-4
| -0% | -$524 | 1.38% | 19 |
|
|
2019
Q1 | $3.67M | Sell |
27,117
-1,000
| -4% | -$135K | 1.47% | 18 |
|
|
2018
Q4 | $2.74M | Hold |
28,117
| – | – | 1.17% | 20 |
|
|
2018
Q3 | $3.86M | Sell |
28,117
-31
| -0.1% | -$4.25K | 1.5% | 19 |
|
|
2018
Q2 | $3.5M | Sell |
28,148
-1,500
| -5% | -$186K | 1.36% | 20 |
|
|
2018
Q1 | $3.22M | Sell |
29,648
-1,500
| -5% | -$163K | 1.36% | 20 |
|
|
2017
Q4 | $3.73M | Sell |
31,148
-250
| -0.8% | -$29.9K | 1.63% | 19 |
|
|
2017
Q3 | $4.43M | Buy |
31,398
+31,367
| +101,184% | +$4.43M | 2.28% | 17 |
|
|
2017
Q2 | $3.89K | Sell |
31
-31,367
| -100% | -$3.93M | 2.18% | 17 |
|
|
2017
Q1 | $3.65M | Buy |
+31,398
| New | +$3.65M | 2.29% | 17 |
|